Experience

Encodia

• Italy
• Information Technology & Services
• 1 - 100 Employee

• Director of Intellectual Property

  • Dec 2022 - Present

  San Diego, California, United States

• Staff Patent Agent

  • Mar 2022 - Nov 2022

  San Diego, California, United States

• Senior Patent Agent

  • Oct 2020 - Mar 2022

  San Diego, California, United States In-house patent drafting and prosecution of patent applications.



Torrey Pines Law Group - Intellectual Property, Regulatory, and Technology Transactions Law Firm

• Patent Agent

  • Jul 2020 - Present

  San Diego, California, United States



Skolkovo Foundation

• Venture Capital and Private Equity Principals
• 200 - 300 Employee

• Patent Agent

  • Nov 2016 - Oct 2020

  Moscow, Russian Federation • Drafted and prosecuted over 60 patent applications before USPTO, ROSPATENT, EPO, EAPO, CNIPA, KIPO. Obtained over 12 U.S. patents, 30 Russian (RU) patents. Supervised USPTO patent filings for the firm. Managed a daily caseload of 3 to 5 active complex cases. • Provided a global IP support for biotech and pharma start-up companies that reside at the Skolkovo Innovation Center (BioMedical cluster, more than 300 companies). Counseling multiple clients on IP-related issues on regular basis… Show more • Drafted and prosecuted over 60 patent applications before USPTO, ROSPATENT, EPO, EAPO, CNIPA, KIPO. Obtained over 12 U.S. patents, 30 Russian (RU) patents. Supervised USPTO patent filings for the firm. Managed a daily caseload of 3 to 5 active complex cases. • Provided a global IP support for biotech and pharma start-up companies that reside at the Skolkovo Innovation Center (BioMedical cluster, more than 300 companies). Counseling multiple clients on IP-related issues on regular basis. Successfully adopted patent claims in biomedical inventions for filing in different countries in communication with foreign partners. • Prepared more than 30 Freedom-To-Operate (FTO) and prior art searches in different technological areas. Provided services including patent invalidity assessments, patent landscape reports, opposition filings, patent portfolio development and IP due diligence. • Presented 2-3 seminars annually for start-up companies related to IP strategy for biomedical and pharma patenting, specifics of international patenting and other topics. Show less



FDA

• Canada
• Advertising Services
• 1 - 100 Employee

• Staff Fellow

  • May 2014 - Nov 2016

  Silver Spring, MD • Predicted potential issues for safety and efficacy of protein-based biotechnology drugs. Published 4 peer-reviewed scientific articles on quality of biotechnology products. Critically evaluated research data, prepared summary reports on specific topics related to OBP-regulated drugs, medical conditions, biomarkers. Performed multiple presentations for both internal and external audiences. • Applied a risk-based approach to protein drug formulation excipients, and evaluated their effects… Show more • Predicted potential issues for safety and efficacy of protein-based biotechnology drugs. Published 4 peer-reviewed scientific articles on quality of biotechnology products. Critically evaluated research data, prepared summary reports on specific topics related to OBP-regulated drugs, medical conditions, biomarkers. Performed multiple presentations for both internal and external audiences. • Applied a risk-based approach to protein drug formulation excipients, and evaluated their effects on stability of therapeutic proteins. Developed and applied several analytical methods to characterize critical quality attributes for therapeutic proteins. Investigated impact of protein oxidation and aggregation on immunogenicity; analyzed T cell responses to sub-visible particles. Show less



Landon IP

• United Kingdom
• Legal Services
• 1 - 100 Employee

• Patent Analyst

  • Sep 2013 - Jun 2014

  Alexandria, VA Prepared International Search Reports and written opinions for USPTO PCT applications related to biotechnology and pharmaceutical inventions. Performed extensive prior art search and analysis.



Uniformed Services University of the Health Sciences

• Postdoctoral Scientist

  • Mar 2011 - Apr 2014

  Bethesda, MD • Co-investigator on an NIH R03 Investigational grant (about $500,000). Published 8 scientific articles as a lead author. Prepared several grant applications (NIH, NSF). Designed and completed several interdisciplinary research projects, supervising junior lab members. • Designed and implemented high-throughput small molecule screening based on cytotoxicity of the aggregation-prone protein FUS. Designed and implemented a novel mass spectrometry-based approach for identification of new… Show more • Co-investigator on an NIH R03 Investigational grant (about $500,000). Published 8 scientific articles as a lead author. Prepared several grant applications (NIH, NSF). Designed and completed several interdisciplinary research projects, supervising junior lab members. • Designed and implemented high-throughput small molecule screening based on cytotoxicity of the aggregation-prone protein FUS. Designed and implemented a novel mass spectrometry-based approach for identification of new amyloid proteins. Studied liver pathogenesis after traumatic brain injury (TBI) using a TBI mouse model. Quantified chemokines and cytokines expression after TBI. Characterized protein stability, conformation and aggregation by a variety of biophysical techniques. Show less



National Institutes of Health

• Research Services
• 200 - 300 Employee

• Postdoctoral Fellow

  • Jan 2006 - Jan 2011

  Bethesda, MD • Published 17 scientific peer-reviewed articles. Developed and completed several interdisciplinary research projects, supervising graduate students. Performed multiple presentations for both internal and external audiences. • Developed high-throughput proteomic (mass spectrometry) and genomic screens (phenotype-based) for identification of prion-interacting proteins. Successfully modeled neurodegenerative disease (Prion, Alzheimer, Batten)-related conditions in microbial and mammalian… Show more • Published 17 scientific peer-reviewed articles. Developed and completed several interdisciplinary research projects, supervising graduate students. Performed multiple presentations for both internal and external audiences. • Developed high-throughput proteomic (mass spectrometry) and genomic screens (phenotype-based) for identification of prion-interacting proteins. Successfully modeled neurodegenerative disease (Prion, Alzheimer, Batten)-related conditions in microbial and mammalian cells. Studied cellular stress developed by accumulation of protein aggregates. Purified recombinant proteins in large scales using HPLC. Utilized mass spectrometry, solid state NMR (in collaboration with Dr. Robert Tycko, NIH) to probe the core structure of prion aggregates. Show less



Ludwig-Maximilians-University of Munich

• Research Services
• 1 - 100 Employee

• Visiting Scientist

  • Nov 2004 - Dec 2005

  Munich Area, Germany • Developed purification methods for gamma-secretase complex involved in Alzheimer disease. • Reconstituted in vivo and conducted studies of structural organization of gamma-secretase complex.



Cardiology Research Center, Moscow, Russia

• Research Assistant

  • Jun 2001 - Sep 2004

  Moscow, Russian Federation Developed novel method for purification and analysis of amyloid and prion aggregates (SDD-AGE). Biochemically characterized different yeast prion strains. Completed high throughput genomic study of the yeast prion-interacting proteins. Explored evolutionary conservation of prion properties.